Targeting signaling pathways involved in primordial follicle growth or dormancy : potential application in prevention of follicular loss and infertility
INTRODUCTION: Premature ovarian failure (POF) is one of the important causes of infertility in females. To date, no efficient preventive pharmacological treatment has been offered to prevent POF. Therefore, it is necessary to focus on strategies that provide a normal reproductive lifespan to females at risk of developing POF.
AREAS COVERED: Recently, attention has been drawn to discovering pathways involved in primordial follicle activation, as the inhibition of this process might maintain the stock of primordial follicles and therefore, prevent POF. In vitro and animal studies have resulted in the discovery of several of these pathways that can be used to develop new treatments for POF. These studies show crosstalk of these pathways at different levels. One of the important crossing points of many of these pathways involves anti-Mullerian hormone (AMH). Herein, we discuss different aspects of this topic by reviewing related published articles indexed in PubMed and Web of Science as of December 2021.
EXPERT OPINION: Although the findings seem promising, most of the studies were conducted on animals, and the interaction between these factors and the possible outcomes of their administration in the long term are still unknown. Therefore, further investigation is necessary to assess these aspects.
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2022 |
|---|---|
| Erschienen: |
2022 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:22 |
|---|---|
| Enthalten in: |
Expert opinion on biological therapy - 22(2022), 7 vom: 21. Juli, Seite 871-881 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Farhat, Sara Ali [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
80497-65-0 |
|---|
| Anmerkungen: |
Date Completed 20.07.2022 Date Revised 15.09.2022 published: Print-Electronic Citation Status MEDLINE |
|---|
| doi: |
10.1080/14712598.2022.2086042 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM341806196 |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM341806196 | ||
| 003 | DE-627 | ||
| 005 | 20231226012623.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231226s2022 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1080/14712598.2022.2086042 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1139.xml |
| 035 | |a (DE-627)NLM341806196 | ||
| 035 | |a (NLM)35658707 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Farhat, Sara Ali |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Targeting signaling pathways involved in primordial follicle growth or dormancy |b potential application in prevention of follicular loss and infertility |
| 264 | 1 | |c 2022 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Completed 20.07.2022 | ||
| 500 | |a Date Revised 15.09.2022 | ||
| 500 | |a published: Print-Electronic | ||
| 500 | |a Citation Status MEDLINE | ||
| 520 | |a INTRODUCTION: Premature ovarian failure (POF) is one of the important causes of infertility in females. To date, no efficient preventive pharmacological treatment has been offered to prevent POF. Therefore, it is necessary to focus on strategies that provide a normal reproductive lifespan to females at risk of developing POF | ||
| 520 | |a AREAS COVERED: Recently, attention has been drawn to discovering pathways involved in primordial follicle activation, as the inhibition of this process might maintain the stock of primordial follicles and therefore, prevent POF. In vitro and animal studies have resulted in the discovery of several of these pathways that can be used to develop new treatments for POF. These studies show crosstalk of these pathways at different levels. One of the important crossing points of many of these pathways involves anti-Mullerian hormone (AMH). Herein, we discuss different aspects of this topic by reviewing related published articles indexed in PubMed and Web of Science as of December 2021 | ||
| 520 | |a EXPERT OPINION: Although the findings seem promising, most of the studies were conducted on animals, and the interaction between these factors and the possible outcomes of their administration in the long term are still unknown. Therefore, further investigation is necessary to assess these aspects | ||
| 650 | 4 | |a Journal Article | |
| 650 | 4 | |a Review | |
| 650 | 4 | |a Female fertility | |
| 650 | 4 | |a anti-mullerian hormone | |
| 650 | 4 | |a folliculogenesis | |
| 650 | 4 | |a ovarian failure | |
| 650 | 4 | |a primordial follicle growth | |
| 650 | 4 | |a signaling pathway | |
| 650 | 7 | |a Anti-Mullerian Hormone |2 NLM | |
| 650 | 7 | |a 80497-65-0 |2 NLM | |
| 700 | 1 | |a Jabbari, Forouq |e verfasserin |4 aut | |
| 700 | 1 | |a Jabbari, Parnian |e verfasserin |4 aut | |
| 700 | 1 | |a Rezaei, Nima |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Expert opinion on biological therapy |d 2001 |g 22(2022), 7 vom: 21. Juli, Seite 871-881 |w (DE-627)NLM116190124 |x 1744-7682 |7 nnns |
| 773 | 1 | 8 | |g volume:22 |g year:2022 |g number:7 |g day:21 |g month:07 |g pages:871-881 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1080/14712598.2022.2086042 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 22 |j 2022 |e 7 |b 21 |c 07 |h 871-881 | ||